0000896262-22-000022.txt : 20220404
0000896262-22-000022.hdr.sgml : 20220404
20220404205733
ACCESSION NUMBER: 0000896262-22-000022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220329
FILED AS OF DATE: 20220404
DATE AS OF CHANGE: 20220404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kemmerly David L
CENTRAL INDEX KEY: 0001673554
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24260
FILM NUMBER: 22804950
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMEDISYS INC
CENTRAL INDEX KEY: 0000896262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 113131700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
BUSINESS PHONE: 2252922031
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
FORMER COMPANY:
FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP
DATE OF NAME CHANGE: 19940819
FORMER COMPANY:
FORMER CONFORMED NAME: M&N CAPITAL CORP
DATE OF NAME CHANGE: 19930125
4
1
wf-form4_164912023751455.xml
FORM 4
X0306
4
2022-03-29
0
0000896262
AMEDISYS INC
AMED
0001673554
Kemmerly David L
3854 AMERICAN WAY, SUITE A
BATON ROUGE
LA
70816
0
1
0
0
See Remarks
Common Stock
2022-03-29
4
S
0
20
175.16
D
18816
D
Common Stock
2022-03-29
4
S
0
2037
177.21
D
16779
D
Common Stock
2022-03-29
4
S
0
443
177.89
D
16336
D
Common Stock
506
I
Through 401(k) Plan
These sales were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
The total amount of shares beneficially owned includes 292 shares held in an employee stock purchase plan account.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.66 to $177.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.66 to $178.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
The information in this report is based on a plan statement dated as of December 31, 2021.
Chief Legal & Government Affairs Officer
/s/ Jennifer R. Guckert, pursuant to a power of attorney
2022-04-04